tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market
LXEO
Lexeo Therapeutics, Inc.
RESEARCH TOOLSreports

Lexeo Therapeutics, Inc. (LXEO) Cash flow

289 Followers

Lexeo Therapeutics, Inc. Cash Flow

LXEO's free cash flow for Q4 2025 was $-20.08M. For the 2025 fiscal year, LXEO's free cash flow was decreased by $-17.33M and operating cash flow was $-20.08M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -98.56M$ -81.15M$ -59.50M$ -54.56M$ -44.18M
Investing Cash Flow
$ -90.25M$ -94.08M$ -165.00K$ -901.00K$ -188.00K
Financing Cash Flow
$ 216.79M$ 88.78M$ 103.79M$ 189.00K$ 150.86M
End Cash Position
$ 66.25M$ 38.27M$ 124.72M$ 80.59M$ 135.86M
Free Cash Flow
$ -98.96M$ -81.63M$ -59.66M$ -55.46M$ -44.37M
Currency in USD

Lexeo Therapeutics, Inc. Cash Flow